Your Health, We Care
During treatment with LuciDarax(Daraxonrasib), please have blood counts and biochemistry tests reviewed as directed by your physician. If severe rash, an increase in bowel movement···【more】
Article source：Lucius LaosRelease date：2026-10-14Recommended：145
Before using LuciDarax(Daraxonrasib), prophylactic skin care is required. Prepare topical glucocorticoids (to be applied to the face and chest as directed by the physician), a whol···【more】
Article source：Lucius LaosRelease date：2026-10-14Recommended：142
The recommended dose of LuciDarax(Daraxonrasib) is 300 mg, orally, once daily, until disease progression or unacceptable toxicity. LuciDarax(Daraxonrasib) is available only as 100 ···【more】
Article source：Lucius LaosRelease date：2026-10-12Recommended：169
LuciDarax(Daraxonrasib) is an oral pan-RAS inhibitor for adults with metastatic pancreatic adenocarcinoma whose disease has failed at least one prior line of systemic therapy or wh···【more】
Article source：Lucius LaosRelease date：2026-10-12Recommended：224
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Name: Lucius
Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643
